ODI Pharma AB (publ) (NGM:ODI)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.600
+0.120 (8.11%)
At close: Dec 4, 2025
-50.00%
Market Cap 30.98M
Revenue (ttm) 8.96M
Net Income (ttm) -4.50M
Shares Out 18.33M
EPS (ttm) -0.23
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,328
Average Volume 8,217
Open 1.550
Previous Close 1.480
Day's Range 1.510 - 1.600
52-Week Range 1.000 - 4.000
Beta 0.42
RSI 57.34
Earnings Date Nov 27, 2025

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In 2025, ODI Pharma AB's revenue was 3.13 million, a decrease of -85.94% compared to the previous year's 22.29 million. Losses were -5.93 million, 944.5% more than in 2024.

Financial Statements

News

There is no news available yet.